Critical insights from this audience include: The dietary patterns of patients taking GLP-1 medications, including food categories and portion size The potential long-term impact of side effects The reasons behind healthcare professionals recommending or not recommending GLP-1 medications With this report, you will receive: In-depth Briefing Deck: 50+ slides covering a global overview of GLP-1s and exclusive insights on GLP-1 medications from healthcare professionals Executive Summary: 3-5 essential implications and actionable insights to inform decisions on product formulations and portfolio adjustments One-Page Infographic : A single, impactful sheet distilled from the in-depth briefing deck to share the main takeaways and business impacts of GLP-1 with key internal stakeholders
Peter Kongstvedt, M.D., a senior health policy faculty member in the Department of Health Administration and Policy at George Mason University, told Fierce Healthcare in an email that the evidence is there that these drugs work to help people lose weight
If more than 4 days have passed, skip that dose entirely and take your next dose on the regularly scheduled day
Tirzepatide starts at 2.5 mg weekly (Mounjaro), increasing by 2.5 mg every 4 weeks until the desired maintenance dose (up to 15 mg ) is reached
Until a regulator approves a specific product in your jurisdiction, its use should be viewed through the lens of clinical research, not routine treatment
This sudden volume loss can be both physically and emotionally uncomfortable, especially among those who previously had significant volume in that area
